Nuclear Receptor Coactivator NCOA3 Regulates UV Radiation-Induced DNA Damage and Melanoma Susceptibility.
Autor: | de Semir D; Center for Melanoma Research and Treatment, California Pacific Medical Center Research Institute, San Francisco, California.; California Pacific Medical Center Research Institute, San Francisco, California., Bezrookove V; Center for Melanoma Research and Treatment, California Pacific Medical Center Research Institute, San Francisco, California.; California Pacific Medical Center Research Institute, San Francisco, California., Nosrati M; Center for Melanoma Research and Treatment, California Pacific Medical Center Research Institute, San Francisco, California.; California Pacific Medical Center Research Institute, San Francisco, California., Dar AA; Center for Melanoma Research and Treatment, California Pacific Medical Center Research Institute, San Francisco, California.; California Pacific Medical Center Research Institute, San Francisco, California., Miller JR 3rd; Center for Melanoma Research and Treatment, California Pacific Medical Center Research Institute, San Francisco, California.; California Pacific Medical Center Research Institute, San Francisco, California., Leong SP; Center for Melanoma Research and Treatment, California Pacific Medical Center Research Institute, San Francisco, California.; California Pacific Medical Center Research Institute, San Francisco, California., Kim KB; Center for Melanoma Research and Treatment, California Pacific Medical Center Research Institute, San Francisco, California.; California Pacific Medical Center Research Institute, San Francisco, California., Liao W; Department of Dermatology, University of California San Francisco, San Francisco, California., Soroceanu L; California Pacific Medical Center Research Institute, San Francisco, California., McAllister S; California Pacific Medical Center Research Institute, San Francisco, California., Debs RJ; California Pacific Medical Center Research Institute, San Francisco, California., Schadendorf D; Department of Dermatology, University Duisburg-Essen, Essen, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany., Leachman SA; Department of Dermatology and Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon., Cleaver JE; Department of Dermatology, University of California San Francisco, San Francisco, California., Kashani-Sabet M; Center for Melanoma Research and Treatment, California Pacific Medical Center Research Institute, San Francisco, California. kashani@cpmcri.org.; California Pacific Medical Center Research Institute, San Francisco, California. |
---|---|
Jazyk: | angličtina |
Zdroj: | Cancer research [Cancer Res] 2021 Jun 01; Vol. 81 (11), pp. 2956-2969. Date of Electronic Publication: 2021 Mar 25. |
DOI: | 10.1158/0008-5472.CAN-20-3450 |
Abstrakt: | Melanoma occurs as a consequence of inherited susceptibility to the disease and exposure to UV radiation (UVR) and is characterized by uncontrolled cellular proliferation and a high mutational load. The precise mechanisms by which UVR contributes to the development of melanoma remain poorly understood. Here we show that activation of nuclear receptor coactivator 3 (NCOA3) promotes melanomagenesis through regulation of UVR sensitivity, cell-cycle progression, and circumvention of the DNA damage response (DDR). Downregulation of NCOA3 expression, either by genetic silencing or small-molecule inhibition, significantly suppressed melanoma proliferation in melanoma cell lines and patient-derived xenografts. NCOA3 silencing suppressed expression of xeroderma pigmentosum C and increased melanoma cell sensitivity to UVR. Suppression of NCOA3 expression led to activation of DDR effectors and reduced expression of cyclin B1, resulting in G (©2021 American Association for Cancer Research.) |
Databáze: | MEDLINE |
Externí odkaz: |